EU identifies severe allergic reactions as side effects of Novavax COVID vaccine

The EMA said it would also update the product information for the vaccine to add unusual or decreased feeling in the skin as a new side effect.

Published On 2022-07-15 11:00 GMT   |   Update On 2022-07-15 11:01 GMT

New Delhi: The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc's COVID-19 vaccine.

The vaccine was authorized by U.S. regulators on Wednesday, and its product label in the United States warns against administering the shot to people with a history of allergic reactions to any components of the shot.

Shares of Novavax fell 20.3% to $55.72 in morning trading, along with the broader market and other COVID-19 vaccine makers. Novavax shares are usually volatile.

Read also: Novavax COVID vaccine Nuvaxovid gets European Commission conditional nod for adolescents

The EMA said it would also update the product information for the vaccine to add unusual or decreased feeling in the skin as a new side effect.

Only 250,000 doses of Novavax's COVID vaccine, Nuvaxovid, have been administered in Europe so far since its launch in December, according to the European Centre for Disease Prevention and Control

Read also: Novavax COVID vaccine gets USFDA emergency use nod for 18 years and older

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News